SomaLogic, Inc.

SomaLogic, Inc., filing under the ticker CMII, submitted an 8-K with the Securities and Exchange Commission on January 5, 2024, marking a notable development in the company's corporate timeline. CMII is associated with the CM Life Sciences SPAC sponsor family, which has focused on the life sciences and healthcare technology sector across multiple blank-check vehicles. SomaLogic, a proteomics and life sciences data company, entered the public markets through a SPAC transaction and has navigated ongoing corporate developments in the years since. The January 2024 filing reflects activity during an active period of consolidation across the life sciences SPAC landscape. For complete filing history, sponsor profiles, and deal analytics on CMII and related vehicles, sign up for full data access at SpacDesk.